Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OFATUMUMAB Cause Drug effect less than expected? 319 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 319 reports of Drug effect less than expected have been filed in association with OFATUMUMAB (ARZERRA). This represents 1.1% of all adverse event reports for OFATUMUMAB.

319
Reports of Drug effect less than expected with OFATUMUMAB
1.1%
of all OFATUMUMAB reports
1
Deaths
14
Hospitalizations

How Dangerous Is Drug effect less than expected From OFATUMUMAB?

Of the 319 reports, 1 (0.3%) resulted in death, 14 (4.4%) required hospitalization, and 4 (1.3%) were considered life-threatening.

Is Drug effect less than expected Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 319 reports have been filed with the FAERS database.

What Other Side Effects Does OFATUMUMAB Cause?

Fatigue (5,202) Headache (4,430) Pain (3,382) Chills (3,372) Pyrexia (3,370) Influenza like illness (2,727) Nausea (1,688) Multiple sclerosis relapse (1,525) Covid-19 (1,435) Asthenia (1,393)

What Other Drugs Cause Drug effect less than expected?

DUPILUMAB (1,204) DICLOFENAC (647) VEDOLIZUMAB (461) PRABOTULINUMTOXINA-XVFS (354) EPTINEZUMAB-JJMR (298) IBUPROFEN (218) TOFACITINIB (210) SECUKINUMAB (190) ACETAMINOPHEN\IBUPROFEN (163) ACETAMINOPHEN\ASPIRIN\CAFFEINE (134)

Which OFATUMUMAB Alternatives Have Lower Drug effect less than expected Risk?

OFATUMUMAB vs OFLOXACIN OFATUMUMAB vs OLANZAPINE OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE OFATUMUMAB vs OLAPARIB OFATUMUMAB vs OLARATUMAB

Related Pages

OFATUMUMAB Full Profile All Drug effect less than expected Reports All Drugs Causing Drug effect less than expected OFATUMUMAB Demographics